63 results
DFAN14A
lbfvd o098cbfps
14 Sep 23
Additional proxy materials by non-management
4:00pm
DFAN14A
jal87q qbp4
6 Sep 23
Additional proxy materials by non-management
4:31pm
DFAN14A
4t5hhd2
25 Aug 23
Additional proxy materials by non-management
5:17pm
DEFC14A
276fzr
25 Aug 23
Proxy in contested solicitation
10:10am
DEFC14A
rlqss090v8gjf97lc
24 Aug 23
Proxy in contested solicitation
6:15am
PRRN14A
vqgo8lq
17 Aug 23
Revised preliminary proxy statement filed by non-management
9:30am
PREC14A
b91jjntppwawjwk
2 Aug 23
Preliminary proxy with contested solicitation
5:28pm
PREC14A
dxcfdn12s882jc
25 May 23
Preliminary proxy with contested solicitation
3:51pm
8-K
hm344c
14 Nov 22
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update
4:05pm